Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer

BACKGROUND AND AIMS: Biomarkers for systemic inflammation have been introduced into clinical practice for risk-rating in cancer patients' treatment. This study is aimed at confirming the prognostic role of the neutrophil-to-lymphocyte ratio (NLR) as an effective biomarker for patients with meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Miaomiao, Qu, Tongtong, Wang, Zhikuan, Yan, Huan, Si, Yanhai, Zhang, Yong, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727102/
https://www.ncbi.nlm.nih.gov/pubmed/34993252
http://dx.doi.org/10.1155/2021/2549295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727102/
https://www.ncbi.nlm.nih.gov/pubmed/34993252
http://dx.doi.org/10.1155/2021/2549295

Ejemplares similares